MedAdvisor Stock

MedAdvisor Dividend

Delisted

Dividend of MedAdvisor (MDR.AX) as of Aug 5, 2026.

Dividend

0.00AUD

Last updated:

How much dividend does MedAdvisor 2026 pay?

According to the latest status from August 2026, MedAdvisor paid a total of 0.00 AUD per share in dividends within the last 12 months. With the current MedAdvisor price of 0.00 AUD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical MedAdvisor Dividends

PaydateDividend

Is the MedAdvisor Dividend Safe?

MedAdvisor has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding MedAdvisor's Dividend Distributions

MedAdvisor’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining MedAdvisor's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

MedAdvisor's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in MedAdvisor’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

MedAdvisor Stock analysis

What does MedAdvisor do? Medadvisor Ltd is an Australian company that offers a digital platform for healthcare. Founded in 2012 by Robert Read, David Liu, and Josh Swinnerton, their aim was to develop a platform that simplifies medication management for patients, pharmacies, and doctors. Today, Medadvisor is a publicly traded company with a wide range of digital healthcare solutions. They offer various solutions to support patients in medication intake and management, such as a mobile application that allows patients to manage their medications, order prescriptions, and receive reminders. They also offer solutions for pharmacies, including an online ordering system and access to electronic patient history, as well as a platform for doctors to electronically issue prescriptions. One of their latest products is a mobile application that facilitates the handling of COVID-19, providing real-time virus spread tracking and symptom tracking tools. Medadvisor focuses on meeting customer needs and continuously improving the healthcare process. They recently partnered with Take2 Healthcare to expand their range of solutions and create the best offering of health solutions. Overall, Medadvisor plays an important role in the Australian healthcare system by helping their customers live happier and healthier lives through innovative technologies and services. MedAdvisor is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MedAdvisor stock

MedAdvisor is assigned to the 'Health' sector.

The dividends of MedAdvisor are distributed in AUD.

Dividend calendar 2026
Access this data via the Eulerpool API
Get Free API Key

All Key Metrics — MedAdvisor